Facial cutaneous Rosai-Dorfman disease: A case report and literature review

Fang,Sheng; Chen,Ai‑Jun

doi:10.3892/etm.2015.2260

Facial cutaneous Rosai-Dorfman disease: A case report and literature review

Authors:
- Sheng Fang
- Ai‑Jun Chen
View Affiliations

Affiliations: Department of Dermatology, The First Affiliated Hospital of Chongqing Medical University, Chongqing 400016, P.R. China
Published online on: February 5, 2015 https://doi.org/10.3892/etm.2015.2260
Pages: 1389-1392

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )

Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )

Cited By (CrossRef): 0 citations Loading Articles...

Abstract

Rosai‑Dorfman disease (RDD), otherwise known as sinus histiocytosis with massive lymphadenopathy, is a rare disease. Cutaneous RDD (CRDD) is an extremely rare form of RDD, which is limited to the skin. The present study examined a case of purely CRDD in a 25‑year‑old female patient who presented with a two‑month history of red plaques on her face. In addition, a review of the literature was conducted, where the etiology, pathology, clinical characteristics and treatment of the disease were discussed. From a dermatological perspective, the current study aimed to emphasize the histological features and clinical morphology of cutaneous RDD. Clinicians should have sufficient knowledge to be able to recognize and manage this rare condition. The present study found that the presence of reddish‑yellow nodules on the face without any particular sensitivity may be useful in the diagnosis of CRDD. Treatment with topical steroids was found to be beneficial in alleviating CRDD.

View Figures

View References

1	Destombes P: Adenitis with lipid excess, in children or young adults, seen in the Antilles and in Mali (4 cases). Bull Soc Pathol Exot Filiales. 58:1169–1175. 1965.(In French). PubMed/NCBI
2	Rosai J and Dorfman RF: Sinus histiocytosis with massive lymphadenopathy. A newly recognized benign clinicopathological entity. Arch Pathol. 87:63–70. 1969.PubMed/NCBI
3	Rosai J and Dorfman RF: Sinus histiocytosis with massive lymphadenopathy: a pseudolymphomatous benign disorder. Analysis of 34 cases. Cancer. 30:1174–1188. 1972. View Article : Google Scholar : PubMed/NCBI
4	Thawerani H, Sanchez RL, Rosai J and Dorfman RF: The cutaneous manifestations of sinus histiocytosis with massive lymphadenopathy. Arch Dermatol. 114:191–197. 1978. View Article : Google Scholar : PubMed/NCBI
5	Chan CC and Chu CY: Dapsone as a potential treatment for cutaneous Rosai-Dorfman disease with neutrophilic predominance. Arch Dermatol. 142:428–430. 2006. View Article : Google Scholar : PubMed/NCBI
6	Tjiu JW, Hsiao CH and Tsai TF: Cutaneous Rosai-Dorfman disease: remission with thalidomide treatment. Br J Dermatol. 148:1060–1061. 2003. View Article : Google Scholar : PubMed/NCBI
7	Chang LY, Kuo TT and Chan HL: Extranodal Rosai-Dorfman disease with cutaneous, ophthalmic and laryngeal involvement: report of a case treated with isotretinoin. Int J Dermatol. 41:888–891. 2002. View Article : Google Scholar : PubMed/NCBI
8	Frater JL, Maddox JS, Obadiah JM and Hurley MY: Cutaneous Rosai-Dorfman disease: comprehensive review of cases reported in the medical literature since 1990 and presentation of an illustrative case. J Cutan Med Surg. 10:281–290. 2006.
9	Lu CI, Kuo TT, Wong WR and Hong HS: Clinical and histopathologic spectrum of cutaneous Rosai-Dorfman disease in Taiwan. J Am Acad Dermatol. 51:931–939. 2004. View Article : Google Scholar : PubMed/NCBI
10	Brenn T, Calonje E, Granter SR, Leonard N, Grayson W, Fletcher CD and McKee PH: Cutaneous Rosai-Dorfman disease is a distinct clinical entity. Am J Dermatopathol. 24:385–391. 2002. View Article : Google Scholar : PubMed/NCBI
11	Paulli M, Bergamaschi G, Tonon L, Viglio A, Viglio A, Rosso R, Facchetti F, Geerts ML, Magrini U and Cazzola M: Evidence for a polyclonal nature of the cell infiltrate in sinus histiocytosis with massive lymphadenopathy (Rosai-Dorfman disease). Br J Haematol. 91:415–418. 1995. View Article : Google Scholar : PubMed/NCBI
12	Middel P, Hemmerlein B, Fayyazi A, Kaboth U and Radzun HJ: Sinus histiocytosis with massive lymphadenopathy: evidence for its relationship to macrophages and for a cytokine-related disorder. Histopathology. 35:525–533. 1999. View Article : Google Scholar : PubMed/NCBI
13	Mannan AA and Karak AK: Sinus histiocytosis with massive lymphadenopathy (Rosai Dorfman disease): evidence for a dendritic cell derivation? Indian J Pathol Microbiol. 48:300–304. 2005.
14	Levine PH, Jahan N, Murari P, Manak M and Jaffe ES: Detection of human herpesvirus 6 in tissues involved by sinus histiocytosis with massive lymphadenopathy (Rosai-Dorfman disease). J Infect Dis. 166:291–295. 1992. View Article : Google Scholar : PubMed/NCBI
15	Luppi M, Barozzi P, Garber R, Maiorana A, Bonacorsi G, Artusi T, Trovato R, Marasca R and Torelli G: Expression of human herpesvirus-6 antigens in benign and malignant lymphoproliferative diseases. Am J Pathol. 153:815–823. 1998. View Article : Google Scholar : PubMed/NCBI
16	Mehraein Y, Wagner M, Remberger K, Füzesi L, Middel P, Kaptur S, Schmitt K and Meese E: Parvovirus B19 detected in Rosai-Dorfman disease in nodal and extranodal manifestations. J Clin Pathol. 59:1320–1326. 2006. View Article : Google Scholar : PubMed/NCBI
17	Weitzman S and Jaffe R: Uncommon histiocytic disorders: the non-Langerhans cell histiocytoses. Pediatr Blood Cancer. 45:256–264. 2005. View Article : Google Scholar
18	Puppin D Jr, Chavaz P and Harms M: Histiocytic lymphophagocytic panniculitis (Rosai-Dorfman disease): a case report. Dermatology. 184:317–320. 1992. View Article : Google Scholar : PubMed/NCBI
19	Silvestre JF and Aliaga A: Cutaneous sinus histiocytosis and chronic uveitis. Pediatr Dermatol. 17:377–380. 2000. View Article : Google Scholar : PubMed/NCBI
20	Perry BP, Gregg CM, Myers S, Lilly S, Mann KP and Prieto V: Rosai-Dorfman disease (extranodal sinus histiocytosis) in a patient with HIV. Ear Nose Throat J. 77:855–858. 1998.PubMed/NCBI
21	Utikal J, Ugurel S, Kurzen H, Erben P, Reiter A, Hochhaus A, Nebe T, Hildenbrand R, Habenkorn U, Goerdt S and Schadendorf D: Imatinib as a treatment option for systemic non-Langerhans cell histiocytoses. Arch Dermatol. 143:736–740. 2007. View Article : Google Scholar : PubMed/NCBI
22	Gebhardt C, Averbeck M, Paasch U, Ugurel S, Kurzen S, Stumpp P, Simon JC and Treudler R: A case of cutaneous Rosai-Dorfman disease refractory to imatinib therapy. Arch Dermatol. 145:571–574. 2009. View Article : Google Scholar : PubMed/NCBI